Silver Book Fact

The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive
therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.

Kupelian P, Potters L, Khuntia D, Ciezki J. Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy > or =72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer. Int J Radiat Oncol Biol Phys. 2004; 58(1): 25-33. http://www.ncbi.nlm.nih.gov/pubmed/14697417

Reference

Title
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy > or =72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer
Publication
Int J Radiat Oncol Biol Phys
Publication Date
2004
Authors
Kupelian P, Potters L, Khuntia D, Ciezki J
Volume & Issue
Volume 58, Issue 1
Pages
25-33
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • FDA approved cancer advances
     
  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • New Drug Increases Brain Cancer Survival Rate: Temozolomide is the first new drug in over 30 years to treat glioblastoma, a severe form of brain cancer  
  • Based on cost-effectiveness consideration, the preferred screening method for colon cancer is a colonoscopy every 10 years after the age of 50.  
  • Cancer mortality declined more than 2% in 2003, a continuation of the decline that began in 1990.